IRS1 and Alzheimer disease: Its reduction in AD models not only led to increased BACE1 (β-site amyloid precursor protein cleaving enzyme 1) phosphorylation, resulting in higher Aβ deposits, but it also induces insulin resistance by downregulating the insulin receptor (IR) and inhibiting insulin receptor substrate 1 (IRS1) [112].